Back to search

Article

Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes

2020-01-31

Abstract excerpt

Insulin-induced hypoglycemia is a major barrier to the treatment of type-1 diabetes (T1D). Accordingly, it is important that we understand the mechanisms regulating the circulating levels of glucagon – the body’s principal blood glucose-elevating hormone which is secreted from alpha-cells of the pancreatic islets. Varying glucose over the range of concentrations that occur physiologically between the fed and fuel-...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5f678373-8399-5b62-95a5-55532085bb45
DOI
10.1101/2020.01.30.927426
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetesDOI 10.1101/2020.01.30.927426
Select a neighboring publication to make it the new centre.